The complete blood count routine test provides a snapshot of your body's blood production and immunity. The test measures a variety of components in your blood, including red blood cells, white blood ...
Neil Bressler, M.D., a professor of ophthalmology at Johns Hopkins and editor-in-chief of JAMA Ophthalmology, argued that complement inhibition for geographic atrophy is a game changer. His debating ...
Omeros Corporation maintained with Strong Buy rating after securing a $2.1 billion partnership with Novo Nordisk for ...
Novo Nordisk is paying $240 million up front for global rights to zaltenibart, an Omeros drug that blocks the MASP-3 protein to treat diseases caused by excessive activity of the complement system.
A new study offers hope for brain cancer patients facing memory loss from radiotherapy. By blocking a single immune receptor, ...
Zaltenibart has best-in-class potential across multiple rare blood and kidney disorders and will enhance Novo Nordisk’s Rare ...
(THE CONVERSATION) Every day, your immune system performs a delicate balancing act ... meaning it helps turn on the genes necessary for regulatory T cells to develop and function. Without this protein ...
Professor Riedemann's company was founded to translate complement system research into clinical applications, aiming to improve patient care. The pandemic shifted healthcare priorities, but focus is ...
Berlin, N.H.-based North Country Healthcare is outsourcing some of its revenue cycle management functions, a spokesperson confirmed to Becker’s. While some positions will be affected, many ...
Many diseases affect men and women differently. Asthma tends to strike men earlier in life, yet more women develop asthma as they get older. Parkinson's is more common in men, but Alzheimer's is more ...
The artificial intelligence applications most people have grown familiar with in recent years usually take the form of assistants: Chatbots answer questions and respond to prompts, but a human ...
The FDA has granted priority review status for pegcetacoplan (Empaveli) to treat two rare kidney diseases that can lead to kidney failure. Up until now, there hadn’t been any drugs approved ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results